World's Best Scientists 2026 revealed!

D-Index & Metrics

Best Female Scientists

D-Index
107
Citations
49554
World Ranking
1004
National Ranking
607

Medicine

D-Index
111
Citations
54917
World Ranking
5269
National Ranking
2844

Overview

Elizabeth J. Shpall is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research focus lies predominantly in the fields of Medicine, with particular expertise in Hematology, Oncology, Immunology, Molecular Biology, and Genetics.

The scientist has contributed extensively to multiple topics within biomedical research. Key areas include:

  • Hematopoietic Stem Cell Transplantation
  • CAR-T cell therapy research
  • Acute Myeloid Leukemia Research
  • Multiple Myeloma Research and Treatments
  • Immune Cell Function and Interaction
  • Acute Lymphoblastic Leukemia research
  • Chronic Myeloid Leukemia Treatments

Frequent co-authors collaborating with Elizabeth J. Shpall are:

  • Richard E. Champlin
  • Partow Kebriaei
  • Samer A. Srour
  • Uday Popat
  • Jeremy Ramdial

The scientist's work is published predominantly in journals such as:

  • Blood
  • Transplantation and Cellular Therapy
  • Cytotherapy
  • Blood Advances
  • Journal of Clinical Oncology

Significant recent papers include:

  • "Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors" (2020), published in New England Journal of Medicine
  • "Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial" (2024), published in Nature Medicine
  • "Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells" (2020), published in Blood
  • "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events" (2020), published in Journal for ImmunoTherapy of Cancer
  • "Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells" (2021), published in Journal of Clinical Investigation

Best Publications

  • Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    V. Gopalakrishnan;V. Gopalakrishnan;C. N. Spencer;C. N. Spencer;L. Nezi;A. Reuben

  • Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

    Sattva S. Neelapu;Sudhakar Tummala;Partow Kebriaei;William Wierda

  • Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

    Enli Liu;David Marin;Pinaki Banerjee;Homer A. Macapinlac

  • Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

    Hillard M. Lazarus;Omer N. Koc;Steven M. Devine;Peter Curtin

  • Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation

    Stephen J. Brandt;William P. Peters;Susan K. Atwater;Joanne Kurtzberg

  • Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity

    Enli Liu;Yijiu Tong;Gianpietro Dotti;Hila Shaim

  • Generation and testing of clinical-grade exosomes for pancreatic cancer

    Mayela Mendt;Sushrut Kamerkar;Hikaru Sugimoto;Kathleen M. McAndrews

  • High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.

    W P Peters;M Ross;J J Vredenburgh;B Meisenberg

  • Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

    Ann M. Leen;Catherine M. Bollard;Adam M. Mendizabal;Elizabeth J. Shpall

  • Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

    Conrad Russell Y. Cruz;Kenneth P. Micklethwaite;Barbara Savoldo;Carlos A. Ramos

  • Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS

    Marcos de Lima;Daniel Couriel;Peter F. Thall;Xuemei Wang

  • Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.

    E J Shpall;R B Jones;S I Bearman;W A Franklin

  • Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells

    Partow Kebriaei;Harjeet Singh;M. Helen Huls;Matthew J. Figliola

  • Cord-blood engraftment with ex vivo mesenchymal-cell coculture.

    Marcos J.G. de Lima;Ian McNiece;Simon N. Robinson;Mark Munsell

  • Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

    Catherine M. Bollard;Catherine M. Bollard;Stephen Gottschalk;Stephen Gottschalk;Vicky Torrano;Vicky Torrano;Oumar Diouf;Oumar Diouf

  • High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.

    W. P. Peters;Elizabeth Shpall;Roy Jones;G. A. Olsen

  • Transplantation of ex vivo expanded cord blood

    Elizabeth J Shpall;Ralph Quinones;Roger Giller;Chan Zeng

  • Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients

    Laszlo G. Radvanyi;Chantale Bernatchez;Minying Zhang;Patricia S. Fox

  • Mesenchymal stem cell-derived exosomes for clinical use.

    Mayela Mendt;Katayoun Rezvani;Elizabeth Shpall

  • Engineering Natural Killer Cells for Cancer Immunotherapy

    Katayoun Rezvani;Rayne Rouce;Enli Liu;Elizabeth Shpall

Frequent Co-Authors

Richard E. Champlin
Richard E. Champlin The University of Texas MD Anderson Cancer Center
Partow Kebriaei
Partow Kebriaei The University of Texas MD Anderson Cancer Center
Borje S. Andersson
Borje S. Andersson The University of Texas MD Anderson Cancer Center
Issa F. Khouri
Issa F. Khouri The University of Texas MD Anderson Cancer Center
Katayoun Rezvani
Katayoun Rezvani The University of Texas MD Anderson Cancer Center
Catherine M. Bollard
Catherine M. Bollard George Washington University
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Laurence J.N. Cooper
Laurence J.N. Cooper The University of Texas MD Anderson Cancer Center
Peter F. Thall
Peter F. Thall The University of Texas MD Anderson Cancer Center
Marina Konopleva
Marina Konopleva The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online education options in healthcare can open doors to flexible and affordable career pathways beyond traditional medical school. For those interested in healthcare administration, earning a medical billing and coding certification online is a practical route to gain in-demand skills and quickly enter the workforce.

Nursing careers also offer strong demand and diverse opportunities. Prospective nurses can begin their journey at an online nursing school, making it easier for working adults or those with family obligations to study. For nurses seeking career advancement, there are cheapest np programs online that lead to high-paying, autonomous roles as nurse practitioners.

If you wish to pursue leadership, research, or teaching positions in nursing, consider phd in nursing online programs. These advanced degrees provide flexibility for working professionals and can lead to influential roles within healthcare systems, research institutions, or academia.

Best Scientists Citing Elizabeth J. Shpall

Trending Scientists

Recently Published Articles